FacebookLinkedInRssXYouTube

Trial Assure

TrialAssure Offers Anonymize 3.0 That Uses Machine Learning And Artificial Intelligence To Share Info

CANTON – Pharmaceutical technology company TrialAssure announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI) to share information with confidence, knowing that patient

By |2024-03-21T15:42:05-04:00March 21st, 2024|Artificial Intelligence|
Read More

TrialAssure AI Creates Plain Language Summaries For 50,000 Drug Studies

DETROIT–Generative artificial intelligence is everywhere, including now the pharmaceutical clinical trial industry. TrialAssure, a company advancing trial results disclosure and data sharing in the pharmaceutical industry, has created and published clinical trial results in plain language summary format, posting directly to TrialResults.com. The documents were created using clinical data provided by the clinical trial sponsors

By |2023-10-20T13:52:01-04:00October 19th, 2023|Artificial Intelligence|
Read More

TrialAssure Partners To Add AI Generative Text Partnership

CANTON -  TrialAssure, a leading software-as-a-service provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it is collaborating with MMS, a global clinical research organization, on a new artificial intelligence initiative aimed at developing generative text specifically for medical writing in the field of drug development. The primary focus of this collaboration

By |2023-08-20T16:48:54-04:00August 20th, 2023|Artificial Intelligence|
Read More